AQST - Aquestive Therapeutics Inc. (AQST) CEO Keith Kendall on Q4 2021 Results - Earnings Call Transcript

Aquestive Therapeutics, Inc. (AQST) Q4 2021 Earnings Conference Call March 9, 2022 08:00 ET Company Participants Bennett Watson - Investor Relations Keith Kendall - Chief Executive Officer Ernie Toth - Chief Financial Officer Dan Barber - Chief Operating Officer Conference Call Participants Gary Nachman - BMO Capital Markets Jason Butler - JMP Securities Thomas Flaten - Lake Street Capital Ram Selvaraju - H.C. Wainwright Presentation Operator Good morning and welcome to the Aquestive Therapeutics Fourth Quarter and Full Year 2021 Conference Call. At this time, all participants are in listen-only mode. [Operator Instructions] As a reminder, this call will be recorded. I would now like to introduce your host for today’s conference call, Bennett Watson of Westwicke Investor Relations. You may begin. Bennett Watson Thank you, operator. Good morning and welcome to today’s call. On today’s call, I am joined by Keith Kendall, Chief Executive Officer and Ernie Toth, Chief

For further details see:

Aquestive Therapeutics, Inc. (AQST) CEO Keith Kendall on Q4 2021 Results - Earnings Call Transcript